Our results revealed significant overexpression of PYGO2 protein in the ESCC samples and supported the hypothesis that PYGO2 can be a new molecular marker of invasiveness in patients with ESCC. The gene discussed is PYGO2; the disease is esophageal squamous cell carcinoma.